Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-13T04:00:03.807Z Has data issue: false hasContentIssue false
  • English
  • Français

CRUCIAL FACTORS THAT INFLUENCE COST-EFFECTIVENESS OF UNIVERSAL HEPATITIS B IMMUNIZATION IN INDIA

Published online by Cambridge University Press:  22 January 2003

Charu Prakash
Charu Prakash
Affiliation:
Takemi Fellow, Harvard University
Get access Rights & Permissions [Opens in a new window]

Abstract

This study examines the parameters crucial to cost-effectiveness of universal hepatitis B immunization in India. An incremental cost-effectiveness analysis was done using a decision tree (Markov model) to follow up a hypothetical cohort of 100,000 newborns for the effects of hepatitis B acquired vertically at birth. The measure of effectiveness was disability-adjusted life-years gained. Uncertainty analysis and Scenario analysis were done using Latin hypercube sampling. Hepatitis B endemicity is the most important factor, followed by the cost of vaccine. Other factors of some influence are vaccination coverage, vaccine efficacy, HBeAg positivity, and vaccine wastage.

Keywords

Hepatitis BUniversal immunizationCost-effectivenessDALY
Type
GENERAL ESSAYS
Information
International Journal of Technology Assessment in Health Care , Volume 19 , Issue 1 , January 2003 , pp. 28 - 40
Copyright
© 2003 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)